Alfredo Ruggero Galassi, MD

Prophylactic Abciximab in Elective Coronary Stenting: Results of a Randomized Trial

08/01/2008

Giovanni Russo , MD;

Antonino Nicosia , MD;

Rosario Foti , MD;

V. Scriffignano , DSc;

Giuseppe Giuffrida , MD;

Alfredo Ruggero Galassi , MD;

Corrado Tamburino , MD, PhD, FESC, FSCAI;

Dean J. Kereiakes , MD, FACC, FSCAI;

Recent large randomized trials have shown that abciximab [a potent inhibitor of platelet aggregation via glycoprotein (GP) IIb/IIIa blockade] is a safe and effective drug in reducing the incidence of death, myocardial infarction and the need...

Recent large randomized trials...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Two-Year Clinical Follow Up of Coronary Drug-Eluting Stent in
Patients at High Risk for Coronary Restenosis

08/01/2008

Alfredo Ruggero Galassi , MD;

Salvatore Azzarelli , MD;

Francesco Amico , MD;

Michele Giacoppo , MD;

Vincenzo Argentino , MD;

Antonio Fiscella , MD;

Drug-eluting stents (DES), compared with bare-metal stents (BMS), have shown a clear superiority in the prevention of restenosis and the need for further revascularization in randomized, controlled trials.1–5 Accordingly, the superiority of...

Drug-eluting stents (DES),...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Treatment of Multilesion Coronary Artery Disease with Simultaneous Drug-Eluting (Full title below)

04/06/2009

Piera Capranzano , MD;

Davide Capodanno , MD;

Corrado Tamburino , MD, PhD, FESC, FSCAI;

Francesca Mirabella , MD;

Bruno Francaviglia , MD;

Maria Elena Di Salvo , MD;

Gian Paolo Ussia , MD;

Alfredo Ruggero Galassi , MD;

From the Department of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy. The authors report no conflicts of interest regarding the content herein. Manuscript submitted October 29, 2008, provisional acceptance given...

From the Department of...

04/06/2009

Journal of Invasive Cardiology

Original Contribution

Long-Term Outcomes Comparison of Different Types of DES in Elderly Patients from a Real-World Experience

07/13/2009

Alessandra Sanfilippo , MD;

Miriam Cumbo , MD;

Anna Maria Caggegi , MD;

Sergio Monaco , MD;

Rita Bucalo , MD;

Cettina Ruperto , MD;

Claudia Tamburino , MD;

Gian Paolo Ussia , MD;

Alfredo Ruggero Galassi , MD;

Piera Capranzano , MD;

Davide Capodanno , MD;

Corrado Tamburino , MD, PhD, FESC, FSCAI;

ABSTRACT: Objective. We sought to evaluate the impact on long-term clinical outcomes of different types of drug-eluting stents (DES) in elderly patients. Background. Elderly patients constitute a fast-growing portion of cardiovascular...

ABSTRACT: Objective. We sought...

07/13/2009

Journal of Invasive Cardiology

Original Contribution

Clinical and Angiographic Outcomes in Elderly Patients Treated with Endothelial Progenitor Cell Capture Coronary Stents: Results from a Prospective Single-Center Registry

12/21/2010

Francesco Amico , MD;

Michele Giacoppo , MD;

Vincenzo Argentino , MD;

Antonio Fiscella , MD;

Giuseppe Grosso , MD;

Alfredo Ruggero Galassi , MD;

Davide Tomasello , MD;

Barbara Campisano , MD;

Salvatore Azzarelli , MD;

NULL

12/21/2010

Journal of Invasive Cardiology

Original Contribution

Current Perspectives and Practices on Chronic Total Occlusion Percutaneous Coronary Interventions

10/15/2017

Alfredo Ruggero Galassi , MD;

Mitul P. Patel , MD;

M. Nicholas Burke , MD;

Rohan V. Menon , BS , MD;

Siddharth M. Patel , MD, BS;

Minh N. Vo , MD;

Dimitrios Karmpaliotis , MD, PhD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Farouc A. Jaffer , MD, PhD;

Robert W. Yeh , MD, MBA, MSc;

Stéphane Rinfret , MD, SM;

Erica Resendes , BS, MS, MPH;

Stephen G. Ellis , MD;

Lorenzo Azzalini , MD, PhD, MSc;

Subhash Banerjee , MD, FSCAI;

Aris Karatasakis , MD;

Kambis Mashayekhi , MD;

Barbara Anna Danek , MD;

Mauro Carlino , MD;

Judit Karacsonyi , MD, PhD;

Bavana V. Rangan , BDS, MPH, MD;

We sought to examine contemporary perspectives and practices on chronic total occlusion percutaneous coronary intervention. An online questionnaire was created and distributed to cardiologists within the United States and internationally.

We sought to examine...

10/15/2017

Journal of Invasive Cardiology

Commentary

Role of Novel Guidewire Support Devices for Crossing Coronary Artery Chronic Total Occlusions

03/01/2016

Alfredo Ruggero Galassi , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Can favorable outcomes for CTO-PCI be achieved at less experienced centers? Bridging the gap in success between experienced and less experienced centers and improving efficiency remain top priorities in 2016.

Can favorable outcomes for...

03/01/2016

Journal of Invasive Cardiology

Original Contribution

Radiation Exposure for Percutaneous Interventions of Chronic Total Coronary Occlusions in a Multicenter Registry: The Influence of Operator Variability and Technical Set-up

03/01/2021

Carlo Di Mario , MD, PhD, FESC, FACC, FRCP;

David Hildick-Smith , MD, MBBS, FRCP;

Antonio Serra-Peñaranda , MD;

Nicolas Boudou , MD;

Joerg Reifart , MD;

Andrea Gagnor , MD;

Markus Meyer-Gessner , MD;

Georgios Sianos , MD, PhD;

Joachim H. Buettner , MD;

Luca Grancini , MD;

Alexander Bufe ;

James C. Spratt , MD, FRCP, BSc, MBChB;

Kambis Mashayekhi , MD;

Artis Kalnins , MD;

Leszek Bryniarski , MD, PhD, FESC;

Alexandre Avran , MD, PhD;

Aigars Lismanis , MD;

Evald Høj Christiansen , MD;

Roberto Garbo , MD;

Karl Isaaz , MD;

Victoria Martin-Yuste , MD, PhD;

Nicolaus Reifart , MD;

Alfredo Ruggero Galassi , MD;

Gerald S. Werner , MD, PhD;

Radiation exposure is a limiting factor for PCI of chronic CTO lesions. This study was designed to analyze changes in patient radiation dose for CTO-PCI and parameters associated with radiation dose.

Radiation exposure is a limiting...

03/01/2021

Journal of Invasive Cardiology

Original Research

A Systematic Review and Meta-Analysis of Clinical Outcomes of Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention

10/13/2022

Santiago Garcia , MD;

Anastasios Milkas , MD, PhD;

Byeong-Keuk Kim , MD, PhD;

M. Nicholas Burke , MD;

Nidal Abi Rafeh , MD;

Jaikirshan J. Khatri , MD;

Lorenzo Azzalini , MD, PhD, MSc;

Kevin J. Croce , MD, PhD;

Michael S. Megaly , MD, MS;

Khaldoon Alaswad , MD;

Amirali Masoumi , MD;

Wissam A. Jaber , MD;

Kambis Mashayekhi , MD;

William J. Nicholson , MD;

Margaret B. McEntegart , MD, PhD, BSc(Hons), MBChB;

Andrea Gagnor , MD;

Seung-Whan Lee , MD, PhD;

Georgios Sianos , MD, PhD;

Scott A. Harding , MD, RT(R)(CV);

Dimitrios Karmpaliotis , MD, PhD;

Alexandre Avran , MD, PhD;

Yangsoo Jang , MD, PhD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Farouc A. Jaffer , MD, PhD;

Darshan Doshi , MD, MS;

Judit Karacsonyi , MD, PhD;

Etsuo Tsuchikane , MD, PhD;

Bahadir Simsek , MD;

Hsien-Li Kao , MD;

Bavana V. Rangan , BDS, MPH, MD;

Carlo Di Mario , MD, PhD, FESC, FACC, FRCP;

Spyridon Kostantinis , MD;

Roberto Garbo , MD;

Alfredo Ruggero Galassi , MD;

Paul Poommipanit , MD, FACC, FSCAI;

Khalid O. Tammam , MD, PhD;

Gerald S. Werner , MD, PhD;

Evangelia Vemmou , MD;

Masahisa Yamane , MD, PhD;

Eugene B. Wu , MD, DM;

Ilias Nikolakopoulos , MD;

Stéphane Rinfret , MD, SM;

Paul Knaapen , MD, PhD;

Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) can improve patient symptoms, but it remains controversial whether it impacts subsequent clinical outcomes.

Chronic total occlusion (CTO)...

10/13/2022

Journal of Invasive Cardiology